InvestorsHub Logo

jeffqdhsr

09/05/18 9:04 AM

#6077 RE: the gipper #6076


I am not day trading this anyway , Everything i have read and most recent news from J&J offering Imet as a preapproved trial drug for me just speaks to J&J commitment in continuing along with

1] Patent Applications [2] Job Postings, [3] Linkedin Profiles Of Janssen Persons responsible for launching Imetelstat in Denmark and Other EU Countries [4] Presentation In EU [5] the 2015 Mayo Clinic Pilot Study " Results Tantamount To A Cure" And <<<<<<<<

Quite Honestly its hard to understand why Imetelstat has not been approved already, If i am not misguided by part or all the above material evidence id have to think J&J will eventually buy them , IMO the patent applications i read are in Janssen name , NOT Geron , So its possible a deal is on paper already and awaiting a "Event" to Potentially Trigger a Buyout ? So looking at stock price daily for me is not IMP , Based on their Comp and past sales i have placed a wide range of #'s on a poss BO figures that i am holding for. Stocks never trade at a ""actual value"" turning to a BO scenario its more about what a Co or bidders are willing to pay for a Co , Often its based on a very broad range based on each of their individual needs, Yes mostly value but there are many other factors,,, ! All JMHO